Protara Therapeutics, Inc.

Healthcare

NASDAQ:TARA · NASDAQ Global Market

Market Cap $145.87M Beta 1.45 P/E (TTM) -2.6

$3.90 +6.85%

+$0.25 today

52W Low $2.77High $7.82

Vol 0.52M · Avg 0.73M

EPS (TTM)-$1.48

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+24.20%

Period High

$7.56

Period Low

$2.78

Latest

$3.90

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

SELLAS Life Sciences Group, Inc.

NASDAQ:SLS

$1.12B

Genfit S.A.

GNFT

$445.68M

Prelude Therapeutics Incorporated

NASDAQ:PRLD

$352.45M

OmniAb, Inc.

NASDAQ:OABI

$270.34M

Orchestra BioMed Holdings, Inc.

NASDAQ:OBIO

$245.51M

Codexis, Inc.

NASDAQ:CDXS

$218.15M

MediWound Ltd.

NASDAQ:MDWD

$154.46M

Invivyd, Inc.

NASDAQ:IVVD

$102.20M

Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

$94.98M

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

$64.96M

What is the latest TARA filing?

The latest filing shown is 424B5 dated May 28, 2026.

How many recent filings does TARA have?

Intrinsic Alpha currently shows 20 recent filings for TARA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.